Genetic Analysis of FBXO2, FBXO6, FBXO12, and FBXO41 Variants in Han Chinese Patients with Sporadic Parkinson’S Disease
Total Page:16
File Type:pdf, Size:1020Kb
Neurosci. Bull. October, 2017, 33(5):510–514 www.neurosci.cn DOI 10.1007/s12264-017-0122-5 www.springer.com/12264 REPORT Genetic Analysis of FBXO2, FBXO6, FBXO12, and FBXO41 Variants in Han Chinese Patients with Sporadic Parkinson’s Disease 1,2 2 1 1 2 Lamei Yuan • Zhi Song • Xiong Deng • Zhijian Yang • Yan Yang • 3 1 1,2 Yi Guo • Hongwei Lu • Hao Deng Received: 24 October 2016 / Accepted: 22 January 2017 / Published online: 24 March 2017 Ó Shanghai Institutes for Biological Sciences, CAS and Springer Science+Business Media Singapore 2017 Abstract Parkinson’s disease (PD) is the second most Keywords Parkinson’s disease Á FBXO2 Á FBXO6 Á common neurodegenerative disorder and has an elusive FBXO12 Á FBXO41 Á Variant etiology. It is likely multifactorial, and genetic defects contribute to its pathogenesis. At least 25 genetic loci and 20 monogenic genes have been identified in monogenic Introduction PD. Recessive F-box protein 7 gene (FBXO7) mutations reportedly cause hereditary parkinsonism. To explore the Parkinson’s disease (PD, OMIM 168600) is a common, roles of four paralogs (FBXO2, FBXO6, FBXO12, and progressive, multifactorial, neurodegenerative disease FBXO41) in PD development, their variants (rs9614, caused by genetic and environmental risk factors [1–3]. It rs28924120, rs6442117, and rs61733550, respectively) is age-related, affecting *1% of the population over 60 were analyzed in 502 Han Chinese patients with PD and years of age, rising to 4% in people over 85 [4, 5]. Motor 556 age, gender, and ethnicity-matched normal participants parkinsonism, defined as bradykinesia plus rigidity or rest in mainland China. Statistically significant differences in tremor, is the cardinal clinical feature [6]. Other motor and genotypic and allelic frequencies were detected only in the non-motor symptoms are also frequently observed in PD FBXO2 variant rs9614 (P = 0.001 and 0.023, respectively; [7]. Pathologically, PD cases have dopaminergic neuronal odds ratio 0.819, 95% confidence interval 0.690–0.973) loss in the substantia nigra pars compacta. Lewy bodies, between patients and controls. These results suggest that which are substantial intracytoplasmic inclusions with the FBXO2 variant rs9614 C allele may decrease the PD ubiquitylated alpha-synuclein, form in surviving neurons risk in mainland Han Chinese and may be a biomarker for [7, 8]. Degeneration and death of dopaminergic neurons in PD. PD are postulated to result from pivotal cellular system impairments, including oxidative stress, mitochondrial dysfunction, disrupted proteolysis referring to the ubiqui- tin-proteasome system or lysosomal autophagy, neuroin- flammation, and/or excitotoxicity [9–11]. Although the & Hongwei Lu pathogenic mechanisms remain unclear, at least 25 loci and [email protected] 20 disease-linked genes have been identified to be & Hao Deng responsible for monogenic PD [7, 12–14]. It has been [email protected] reported that mutations in a critical domain of a gene such as leucine-rich repeat kinase 2 (LRRK2) can cause mono- 1 Center for Experimental Medicine, The Third Xiangya Hospital, Central South University, Changsha 410013, China genic PD, whereas variants in a non-crucial region may either increase the risk or play a protective role [15–17]. 2 Department of Neurology, The Third Xiangya Hospital, Central South University, Changsha 410013, China Known heritable components are responsible for 5%–10% of PD patients. Most cases are sporadic forms resulting 3 Department of Medical Information, Information Security and Big Data Research Institute, Central South University, from a combination of multiple factors [13, 18]. It has been Changsha 410013, China proposed that variants, particularly nucleotide alterations 123 L. Yuan et al.: FBXO2, FBXO6, FBXO12, and FBXO41 Variants in PD 511 causing amino-acid changes in disease-causing genes or F-box genes, including the FBXO7 gene. Four variants in their biologically relevant paralogous genes, play a role in the paralogs of the FBXO7 gene with a frequency [5%, the risk of sporadic PD [12, 19–21]. It has been reported rs9614 (c.353A[C, p.K118T), rs28924120 (c.840G[C, that homozygous or compound heterozygous mutations in p.E280D), rs6442117 (c.496T[C, p.W166R), and the F-box protein 7 gene (FBXO7, OMIM 605648) cause rs61733550 (c.1568G[A, p.R523H), were obtained from hereditary parkinsonism including parkinsonian-pyramidal the public database of single-nucleotide polymorphisms syndrome and typical PD (PARK15, OMIM 260300). This (http://www.ncbi.nlm.nih.gov/SNP/). They were described aroused our interest in evaluating the roles of the F-box as putatively damaging by the bioinformatics tools Sorting gene family [22–25]. In this study, four variants (rs9614, Intolerant from Tolerant (http://sift.jcvi.org/), Polymor- rs28924120, rs6442117, and rs61733550) in the paralogs of phism Phenotyping version 2 (http://genetics.bwh.harvard. FBXO7 (FBXO2, FBXO6, FBXO12, and FBXO41), which edu/pph2/), or MutationTaster (http://www.mutationtaster. putatively alter amino-acids and affect protein functions, org/). No FBXO7 gene variants matched the criteria. The were studied in Han Chinese PD patients. four variants were genotyped using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry following protocols in the iPLEXTM Gold Materials and Methods Application Guide (Agena Bioscience, San Diego, CA) to reveal any potential involvement in PD pathogenesis Participants [20, 29]. Genomic DNA was extracted from peripheral blood using standard protocols [30]. Primers amplifying We recruited 502 patients with sporadic PD (65.7 ± 10.2 short segments for mass spectrometry were designed using years; onset age, 62.3 ± 7.6 years, 63 cases with onset age Sequenom Assay Design 3.1 software (Sequenom Inc., San B50 years; disease duration, 1–26 years; male/female ratio, Diego, CA) and are shown in Table 1. Multiplex and sin- 302/200) and 556 age-, sex-, and ethnicity-matched healthy gle-base extension reactions generated allele-specific short individuals (65.9 ± 10.1 years, male/female ratio, 335/221) products for the MALDI-TOF mass spectrometry assay. from the Third Xiangya Hospital of Central South MassARRAY Typer 4.0 software (Sequenom) obtained the University, Changsha, China. All patients resided in south genotype of samples from spectral peaks [31]. Mass China and were not related. All were examined by expe- spectrometric genotyping concordance was tested by per- rienced neurologists, and the diagnosis of PD was estab- forming Sanger sequencing in 8% of randomized samples lished according to clinical criteria [6, 26]. Written with the Applied Biosystems 3500 Genetic Analyzer (Life informed consent was given by all participants prior to Technologies, Foster City, CA) [20, 30]. Primer pairs for enrollment. This study was approved by the Institutional locus-specific amplification and sequencing were designed Review Board of the Third Xiangya Hospital of Central using online Primer3 (http://primer3.ut.ee/, Table 1), and South University, Changsha, China. the specificity was checked using Primer-BLAST (http:// Some patients were negative for causative mutations in www.ncbi.nlm.nih.gov/tools/primer-blast). PD-associated genes. The following occurred in the fol- lowing percentages of patients: no vacuolar protein sorting Statistical Analysis 35 gene (VPS35) mutations in 24.1% (121/502), no F-box protein 48 gene (FBXO48) mutations in 65.7% (330/502), Statistical analysis was performed using Predictive Ana- or no mutations in the S100 calcium binding protein B gene lytics Software Statistics 18.0 (SPSS Inc., Chicago, IL). (S100B), the alpha-synuclein gene (SNCA), or the RAB39B Genotype and allele frequencies were calculated, and gene (RAB39B, member of RAS oncogene family) in Pearson’s v2 test was applied to genotypic and allelic fre- 74.9% (376/502) [27]. Of those tested, 59.2% (297/502) quency differences. A two-sided P value of 0.05 was set as were negative for point mutations (p.A502V and the threshold for statistical significance [20]. p.R1205H) in the eukaryotic translation initiation factor 4 gamma 1 gene (EIF4G1), and 97.6% (490/502) had no rs10788972 or rs12046178 variants in the transcription Results and Discussion elongation factor A N-terminal and central domain con- taining 2 gene (TCEANC2) [21, 28]. The genotypic and allelic frequencies are summarized in Table 2. No deviation from Hardy-Weinberg equilibrium Variant Genotyping was evident in the normal control cohort (P [0.05). Sta- tistically significant differences in genotypic and allelic The National Center for Biotechnology Information data- frequencies were identified in the FBXO2 variant rs9614 base (http://www.ncbi.nlm.nih.gov/) was used to search for between patients and controls (P = 0.001 and 0.023, 123 512 123 Table 1 Primer sequences for rs9614, rs28924120, rs6442117, and rs61733550. rs9614 rs28924120 rs6442117 rs61733550 Forward primer sequence for amplicon acgttggatgACTGGCA acgttggatgTCTGGACAA acgttggatgAGATGCATCT acgttggatgTGATGACCTCATTGGAGCGT 1a (50?30) GCAGTTCTACTTC CAGCTCGGTAG CGCCATCACT Reverse primer sequence for amplicon acgttggatgTTTCGGCC acgttggatgAACAGCAG acgttggatgATGCAATAAC acgttggatgTCCACGCTCACTTTTGAACC 1a (50?30) CATTTCGCAGCA CATTGTCGTCAG AGGGCTGTGG Amplicon 1 length (bp) 121 121 109 110 Extending primer sequencea (50?30) GTTCTACTTCCTGAGCA GCATGGACAGGAGGA CCACACTTTGATAGTTTTTTTCC cccgaCCACTGCCTCCCTCGGGG Forward primer for amplicon 2b (50?30) GTACCTGGACGAGCTGCC CCCGGCCTGAAAACA GGGCAGAATGAAAGCACAGT CCAGGTAGGTGAAGATGCAGA TTTATTAC